PE-backed Clinical Supplies Management buys TCS assets
Summary
The business will continue to grow under CSM ownership and we look forward to working closely with them on global clinical trials.” Rohan Saikia, Principal at Great Point Partners said, “The acquisition of TCS allows CSM to increase its global presence and add a world-class European team led by TCS’ Executive Director, Rüdiger Weber. This acquisition solidifies CSM’s position as a worldwide service provider in the clinical trials market.” Weber added “CSM has delivered superb just-in time customer service and high quality solutions to the clinical trial packaging and labeling market for the last twenty years. Having access to their North American facilities will also allow us to service our current and future clients globally.” About Great Point Partners Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with approximately $1 billion of equity capital under management and 28 professionals, investing in the United States, Canada, and Western Europe. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. CSM offers a full suite of cGMP-compliant services, continually delivering quality supplies to clinical sites and patients around the world.